Skip to content
Menu

Omeros Corporation OMER

Full chart Compare
Set alert

Price alert · OMER

All alert types
13.21 USD -0.80 (-5.71%)

Regular-session close

13.21 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

13.07 Day range 13.88
8.23 52-week range 21.05
YTD
-23.11%
1 year
+60.51%

Held by funds

78 US ETFs and mutual funds hold OMER · largest positions

  1. VTI 0.00% of fund $31.57M
  2. IWM 0.04% of fund $27.34M
  3. NJM 0.02% of fund $16.36M
  4. VXF 0.02% of fund $15.18M
  5. FSSNX 0.04% of fund $14.84M
  6. BRNY 1.64% of fund $8.92M
  7. XPH 1.59% of fund $8.08M
  8. VTWO 0.04% of fund $7.82M
  9. FSMAX 0.02% of fund $6.31M
  10. IWN 0.05% of fund $6.19M
  11. SCHA 0.03% of fund $5.50M
  12. NLO 0.03% of fund $5.07M
  13. VFMO 0.25% of fund $4.91M
  14. BRES 0.70% of fund $4.16M
  15. VHT 0.02% of fund $3.91M
  16. IHE 0.22% of fund $3.76M
  17. IWO 0.03% of fund $3.73M
  18. IWC 0.28% of fund $3.22M
  19. BBP 2.29% of fund $2.92M
  20. FSKAX 0.00% of fund $2.66M

Ownership

  • Institutions 52.6%
  • Insiders 3.97%
  • Public and other holders 43.5%
Held by insiders 3.97%
Held by institutions 52.56%
Float held by institutions 54.73%
Institutions 258

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Blackrock Inc.8.35%6,046,10184.71MSep 29, 2026
Ingalls & Snyder LLC4.28%3,095,32343.37MSep 29, 2026
Vanguard Capital Management LLC4.22%3,058,09642.84MSep 29, 2026
UBS Group AG4.10%2,970,10741.61MSep 29, 2026
State Street Corporation3.10%2,240,90631.40MSep 29, 2026
Geode Capital Management, LLC2.62%1,895,96126.56MSep 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.00%2,172,33630.43MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.58%1,867,15326.16MSep 29, 2026
Invesco Exchange-Traded Fund Trust-Invesco Biotechnology & Genome ETF1.28%929,58513.02MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.15%831,21811.65MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.09%789,89811.07MAug 30, 2026
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF0.74%533,7507.48MSep 29, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs OMER, and what each was last paid

Gregory A. Demopulos, Co-Founder, Chairman, Chief Executive Officer & PresidentAverage age 61

OMER key executives
NameTitlePayAge
Gregory A. DemopulosCo-Founder, Chairman, Chief Executive Officer & President$1.97M 67
Peter CancelmoVice President, General Counsel & Corporate Secretary$665K 47
David J. BorgesVice President of Finance, Chief Accounting Officer & Treasurer$444K 61
William E. WoodmanVice President & Chief Commercial Officer— —
Catherine A. MelfiChief Regulatory Officer & Vice President of Regulatory Affairs and Quality Systems— 67
George A. GaitanarisChief Scientific Officer & Vice President of Science— 69
Peter W. WilliamsVice President of Human Resources— 58
Pamela Pierce PalmerCo-Founder— 63
David W. GhesquiereVice President & Chief Business Development Officer— 59

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

OMER insiders
InsiderRelationLatest transactionDateShares held
BORGES DAVID J.OfficerSaleSep 22, 20260
CABLE THOMAS JDirectorSaleAug 19, 202635,067
CANCELMO PETER B.General CounselSaleAug 30, 2026200
DEMOPULOS GREGORY A. M.D.Chief Executive OfficerConversion of Exercise of derivative securityFeb 17, 20262,193,250
HANISH ARNOLD CDirectorSaleAug 26, 202612,400